Displaying 1 - 50 of 134 results
Released Company Title Industry Topic
20 Nov 2024
16:11 CET
CROSSJECT Information relative au nombre total de droits de vote et d’actions composant le capital social 20102010 Medical Equipment -
13 Nov 2024
17:30 CET
CROSSJECT Crossject’s ZENEO® Auto-Injector's usability further demonstrated in extreme HAZMAT conditions 20102010 Medical Equipment -
13 Nov 2024
17:30 CET
CROSSJECT Crossject démontre à nouveau la facilité d’utilisation de son auto-injecteur ZENEO® dans une nouvelle étude en conditions extrêmes 20102010 Medical Equipment -
22 Oct 2024
07:30 CEST
CROSSJECT Crossject annonce des progrès majeurs dans la fabrication de son traitement d’urgence ZEPIZURE®, pour la prise en charge des crises d’épilepsie, à l’approche du dépôt d’une demande d’autorisation d’utilisation d’urgence aux États-Unis. 20102010 Medical Equipment -
22 Oct 2024
07:30 CEST
CROSSJECT Crossject reports strong manufacturing progress with its epilepsy rescue therapy ZEPIZURE® ahead of filing U.S. Emergency Use Authorization 20102010 Medical Equipment -
07 Oct 2024
19:00 CEST
CROSSJECT Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social 20102010 Medical Equipment -
07 Oct 2024
19:00 CEST
CROSSJECT Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social 20102010 Medical Equipment -
07 Oct 2024
19:00 CEST
CROSSJECT Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social 20102010 Medical Equipment -
26 Sep 2024
07:30 CEST
CROSSJECT Crossject announces its eligibility for France’s PEA-PME investment scheme 20102010 Medical Equipment -
26 Sep 2024
07:30 CEST
CROSSJECT Crossject annonce son éligibilité au dispositif d’investissement PEA-PME 20102010 Medical Equipment -
23 Sep 2024
18:00 CEST
CROSSJECT Crossject reports financial results and business highlights for the first six months of 2024 20102010 Medical Equipment -
23 Sep 2024
18:00 CEST
CROSSJECT Crossject présente ses résultats financiers et les faits marquants de ses activités pour le premier semestre 2024 20102010 Medical Equipment -
17 Sep 2024
17:30 CEST
CROSSJECT Crossject publiera ses résultats financiers du premier semestre et organisera un webcast le 23 Septembre 2024 20102010 Medical Equipment -
17 Sep 2024
17:30 CEST
CROSSJECT Crossject to report first-half 2024 financial results and host webcast on September 23, 2024 20102010 Medical Equipment -
22 Aug 2024
07:30 CEST
CROSSJECT Crossject participera à la 26ème Annual Global Investment Conference de H.C. Wainwright, 9 au 11 septembre 2024 20102010 Medical Equipment -
22 Aug 2024
07:30 CEST
CROSSJECT Crossject to Present at the H.C. Wainwright 26th Annual Global Investment Conference, September 9th-11th, 2024 20102010 Medical Equipment -
19 Aug 2024
17:30 CEST
CROSSJECT Tony Tipton nommé au poste de directeur des opérations États-Unis de Crossject en vue de la commercialisation de ZEPIZURE®, traitement d'urgence dans la prise en charge des crises d’épilepsie 20102010 Medical Equipment -
19 Aug 2024
17:30 CEST
CROSSJECT Crossject appoints Tony Tipton as U.S. Chief Operating Officer in Preparation for Commercialization of ZEPIZURE® Epilepsy Rescue Treatment 20102010 Medical Equipment -
18 Jul 2024
07:30 CEST
CROSSJECT Crossject achieves key ZEPIZURE® manufacturing milestone 20102010 Medical Equipment -
18 Jul 2024
07:30 CEST
CROSSJECT Crossject franchit une nouvelle étape clé dans la fabrication de ZEPIZURE® 20102010 Medical Equipment -
15 Jul 2024
07:30 CEST
CROSSJECT Crossject to attend H.C. Wainwright 26th Annual Global Investment Conference 20102010 Medical Equipment -
15 Jul 2024
07:30 CEST
CROSSJECT Crossject participera à la 26ème Annual Global Investment Conference de H.C. Wainwright 20102010 Medical Equipment -
10 Jul 2024
07:30 CEST
CROSSJECT Crossject is awarded a 6.9 million euros financing from the French Government, as part of the France 2030 innovation plan, to accelerate the development of ZENEO® Epinephrine 20102010 Medical Equipment -
10 Jul 2024
07:30 CEST
CROSSJECT Crossject obtient 6,9 millions d'euros de financement public dans le cadre du plan France 2030, pour accélérer le développement de ZENEO® Adrénaline 20102010 Medical Equipment -
05 Jul 2024
10:09 CEST
CROSSJECT Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social 20102010 Medical Equipment -
26 Jun 2024
07:30 CEST
CROSSJECT Crossject met en perspective le potentiel de ZEPIZURE® à la lumière de l'étude de référence RAMPART et de sa propre étude de bioéquivalence récemment publiée. 20102010 Medical Equipment -
26 Jun 2024
07:30 CEST
CROSSJECT Crossject elaborates on ZEPIZURE® potential in light of landmark RAMPART study and its own, recently published, bioequivalence study 20102010 Medical Equipment -
18 Jun 2024
12:30 CEST
CROSSJECT Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social 20102010 Medical Equipment -
13 Jun 2024
09:36 CEST
CROSSJECT Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social 20102010 Medical Equipment -
12 Jun 2024
07:30 CEST
CROSSJECT Crossject appoints Dan Chiche, MD as Chief Medical Officer North America 20102010 Medical Equipment -
12 Jun 2024
07:30 CEST
CROSSJECT Crossject nomme Dan Chiche, MD au poste de Directeur Médical Amérique du Nord 20102010 Medical Equipment -
04 Jun 2024
19:30 CEST
CROSSJECT Crossject announces highly successful closing of its €8 million rights offering 20102010 Medical Equipment -
04 Jun 2024
19:30 CEST
CROSSJECT Crossject annonce le vif succès de son augmentation de capital de 8 millions d’euros 20102010 Medical Equipment -
30 May 2024
10:30 CEST
CROSSJECT Crossject announces publication of clinical data on ZEPIZURE ® in Neurology and Therapy 20102010 Medical Equipment -
30 May 2024
10:30 CEST
CROSSJECT Crossject annonce la publication de données cliniques sur ZEPIZURE® dans Neurology and Therapy 20102010 Medical Equipment -
02 May 2024
17:30 CEST
CROSSJECT Crossject signe une extension géographique de l'accord de commercialisation de ZEPIZURE® en Europe 20102010 Medical Equipment -
02 May 2024
17:30 CEST
CROSSJECT Crossject signs a geographic extension of ZEPIZURE® commercialization agreement in Europe 20102010 Medical Equipment -
30 Apr 2024
19:05 CEST
CROSSJECT Crossject annonce le lancement d’une augmentation de capital 20102010 Medical Equipment -
25 Apr 2024
07:32 CEST
CROSSJECT Crossject reports audited financial results for 2023 20102010 Medical Equipment -
25 Apr 2024
07:32 CEST
CROSSJECT Crossject communique ses résultats financiers audités pour 2023 20102010 Medical Equipment -
10 Apr 2024
16:30 CEST
CROSSJECT Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social 20102010 Medical Equipment -
02 Apr 2024
18:35 CEST
CROSSJECT La cotation sur l’action de Crossject à Euronext reprendra comme d’habitude le mercredi 3 avril 20102010 Medical Equipment -
02 Apr 2024
18:35 CEST
CROSSJECT Crossject trading on Euronext to resume as usual on Wednesday April 3 20102010 Medical Equipment -
02 Apr 2024
10:30 CEST
CROSSJECT Crossject advances in its U.S. Strategy and reports Financial Results for 2023 20102010 Medical Equipment -
02 Apr 2024
10:30 CEST
CROSSJECT Crossject poursuit sa stratégie de développement aux États-Unis et publie ses résultats financiers pour 2023 20102010 Medical Equipment -
08 Mar 2024
07:30 CET
CROSSJECT Crossject gender equality score reaches 96/100 in 2024 20102010 Medical Equipment -
08 Mar 2024
07:30 CET
CROSSJECT Le Score de l’index Egalité femmes-hommes chez Crossject atteint 96/100 en 2024 20102010 Medical Equipment -
27 Feb 2024
08:30 CET
CROSSJECT Crossject obtains a financing up to €12 million, in two tranches 20102010 Medical Equipment -
27 Feb 2024
08:30 CET
CROSSJECT Crossject obtient un financement jusqu’à 12 millions d’euros en 2 tranches 20102010 Medical Equipment -
06 Feb 2024
17:30 CET
CROSSJECT Crossject provides strategic update on priorities for 2024 20102010 Medical Equipment -